Gamma-Music Based Intervention for Mild Alzheimer's Disease
Funded at Northeastern University · NIH-11399857 · Data updated 2026-11-12
A non-drug approach using gamma-frequency music and light cues to help people with mild Alzheimer's improve memory and mood.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northeastern University NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 15, 2022 |
| Project end | July 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $557,346 |
| NIH project number | 5R01AG078376-05 |
| Project ID | NIH-11399857 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals diagnosed with mild Alzheimer’s disease or mild Alzheimer’s-type dementia who can participate in music- and light-based activities and attend regular sessions.
✕Less likely to help
Individuals with advanced dementia, significant hearing or vision impairment that would hinder music/light interventions, or those unable to participate for other medical reasons.
What this research studies
This project explores how a music-and-sensory stimulation program that targets gamma brain rhythms may support memory and motivation in people with mild Alzheimer's. By pairing gamma-frequency stimulation with engaging musical experiences, the study aims to promote healthier brain activity and potentially slow cognitive decline. The intervention emphasizes enjoyable, socially engaging activities to encourage daily participation and mood improvement, with careful monitoring of cognitive and functional changes. If successful, it could offer a non-invasive option to complement existing care for Alzheimer’s patients.
Why it matters
Potential benefit: If successful, participants may experience improved memory, mood, and daily functioning, with a non-pharmacological option to slow progression.
How similar studies have gone: Prior research in animals and humans suggests gamma-frequency stimulation can influence brain activity and memory, but translation to routine, lifestyle-based interventions in humans is still being explored.
Where this research is happening
-
Northeastern University
Boston, United States Active
Researchers
- Principal investigator: Loui, Psyche — Northeastern University
- Study coordinator: Loui, Psyche
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.